(Reuters) – Britain has approved the COVID-19 vaccine developed by Novavax for use in those aged 18 and older, the country’s medicines regulator said on Thursday, bringing a fifth coronavirus vaccine to its roster.
(Reporting by Pushkala Aripaka in Bengaluru; Editing by Aditya Soni)
